Article
The binding site of the V-ATPase inhibitor apicularen is in the vicinity of those for bafilomycin and archazolid.
The Journal of biological chemistry - 14 Sept 2012
Osteresch Christin, Bender Tobias, Grond Stephanie, von Zezschwitz Paultheo, Kunze Brigitte, Jansen Rolf, Huss Markus, Wieczorek Helmut
Abstract excerpt
The investigation of V-ATPases as potential therapeutic drug targets and hence of their specific inhibitors is a promising approach in osteoporosis and cancer treatment because the occurrence of these diseases is interrelated to the function of the V-ATPase. Apicularen belongs to the novel inhibitor family of the benzolactone enamides, which are highly potent but feature the unique characteristic of not...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
